Crossmark

SHMT1 inhibits the metastasis of HCC by repressing NOX1-mediated ROS production

Crossref DOI link: https://doi.org/10.1186/s13046-019-1067-5

Published Online: 2019-02-12

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Dou, Changwei

Xu, Qiuran

Liu, Jie

Wang, Yufeng

Zhou, Zhenyu

Yao, Weifeng

Jiang, Kai

Cheng, Jian

Zhang, Chengwu

Tu, Kangsheng https://orcid.org/0000-0002-0032-1459
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (81502092)

National Natural Science Foundation of China (81773123, 81874049)

Innovation Capacity Support Plan in Shaanxi Province of China (2018KJXX-045)
License Information

Text and Data Mining valid from 2019-02-12
More Information

Article History

Received: 25 October 2018

Accepted: 30 January 2019

First Online: 12 February 2019

Ethics approval and consent to participate

: All procedures performed in studies involving human participants were in accordance with the ethical standards of the Research Ethics Committee of Sun Yat-Sen Memorial Hospital and with the 1964 Helsinki declaration and its later amendments. All written informed consent to participate in the study was obtained from HCC patients for samples to be collected from them.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.